New diagnostic advance seen for head, throat cancer

Pharmacy researchers at Oregon State University today announced the discovery of a genetic regulator that is expressed at higher levels in the most aggressive types of head and neck cancers, in work that may help to identify them earlier or even offer a new therapy at some point in the future.

If you want to include this story in your blog, copy and paste this formatted text: